Abstract:Background: The overdiagnosis of prostate cancer (PCa) caused by unnecessary prostate biopsy has become a worldwide problem that urgently requires a solution. We aimed to reduce the unnecessary prostate biopsies and increase the detection rate of clinically significant PCa (csPCa) by creating a novel multiparametric magnetic resonance imaging (mpMRI)-based strategy. Methods: A total of 1,194 eligible patients who underwent transperineal prostate biopsies from January 2018 to December 2022 were included in this retrospective study. Of these patients, 1,080 who received prostate biopsies from January 2018 to July 2022 were regarded as cohort 1 for primary analysis, and 114 patients who received prostate biopsies from August 2022 to December 2022 were collected in cohort 2 for validation. All the mpMRI images were quantitatively evaluated by the Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v. 2.1). The diagnostic performances were assessed through the receiver operating characteristic (ROC) curve and area under the curve (AUC) and were compared with the DeLong test. Cancer diagnosis-free survival analysis was performed using the Kaplan-Meier method and log-rank test. The primary endpoint of this study was clinically significant PCa with an International Society of Urological Pathology (ISUP) grade >= 2. Results: In cohort 1, the results of ROC curves demonstrated that the PI-RADS score had a higher diagnostic accuracy (AUC =0.898 for any-grade PCa; AUC =0.917 for csPCa) than did the other clinical variables (P<0.001). Under the novel mpMRI-based biopsy strategy, all patients with PI-RADS 1 can safely avoid prostate biopsy. For patients with PI-RADS 2, prostate biopsy should be considered for patients with prostate-specific antigen density (PSAD) >= 0.3 ng/mL(2) and prostate volume <65 mL. As for patients with PI-RADS 3, structured surveillance programs can be a viable option if PSAD <0.3 ng/mL(2) and prostate volume >= 65 mL. Finally, patients with a PI-RADS score of 4 and 5 should undergo prostate biopsy due to the high probability of clinically significant PCa. In the validation analysis of cohort 2, 48 patients were placed into a biopsy-spared group with no csPCa cases, while 66 patients were placed in a biopsy-needed group, with an csPCa detection rate of 50.0%. Overall, the novel strategy demonstrated a sensitivity, specificity, positive predictive value, and negative predictive value of 98.9%, 57.5%, 50.5%, and 99.2%, respectively, for diagnosing csPCa. Conclusions: An mpMRI-based biopsy strategy can effectively avoid about 40% of prostate biopsies and maintain a high detection rate for clinically significant PCa. It can further provide valuable guidance for patients and physicians in considering the necessity of prostate biopsy.

Can the Number of Unnecessary MRI-guided Localization be Reduced by Means of Breast MRI Characters?

Application value of MRI-guided wire localization to the non-palpable breast lesions only shown in Breast MRI

MRI-guided Breast Lesion Localization and Lesion Analysis

Utility of the Minimum Apparent Diffusion Coefficient in Decreasing Unnecessary Biopsy Rates for Suspected Breast Magnetic Resonance Imaging Lesions: A Single-Centre, Retrospective Study

The value of MRI for downgrading of breast suspicious lesions detected on ultrasound

Analysis of Cases with MRI Misdiagnosed Breast Lesions

The Diagnostic Value of Breast Magnetic Resonance Imaging for Non-Calcified Malignant Breast Lesions Showed on Mammography: Comparison with Histopathology

[Value of Magnetic Resonance Imaging in Diagnosing Breast Lesions Which Need Biopsy].

Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?

Efficacy of MRI-Directed Breast Ultrasound and Lesion Characteristics Affecting Visualization on Breast Ultrasound

Prospective Evaluation of Ultrasound in a Novel Position with MRI Virtual Navigation for MRI-Detected Only Breast Lesions: A Pilot Study of a More Efficient and Economical Method

Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China

The Accuracy of Preoperatively Predicting Axillary Lymph Node Status in Breast Cancer Patients by Ultrasonography and MRI

Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value-an analysis of 2473 invasive breast cancer patients

Preoperative Magnetic Resonance Imaging Evaluation Improves Breast Conserving Surgery Rate but Not Local Disease Control in Patients with Ductal Carcinoma in Situ

MR Imaging Evalution of Ductal Carcinoma in Situ and Ductal Carcinoma in Situ with Small Invasive Foci of Breast

Subclassification of BI-RADS 4 Magnetic Resonance Lesions: A Systematic Review and Meta-Analysis

Multicenter Prospective Study of Magnetic Resonance Imaging Prior to Breast-Conserving Surgery for Breast Cancer

Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis

A New, Preoperative, MRI-based Scoring System for Diagnosing Malignant Axillary Lymph Nodes in Women Evaluated for Breast Cancer

Creating a Novel Multiparametric Magnetic Resonance Imaging-Based Biopsy Strategy for Reducing Unnecessary Prostate Biopsies: a Retrospective Cohort Study